Amp German Cannabis Group Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amp german cannabis group inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amp German Cannabis Group Inc Today - Breaking & Trending Today

AMP German Cannabis Group and Aphria's subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany

Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)
ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. (
AMP ) (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc. s (
Aphria ) (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (
CC Pharma ), have entered into a strategic agreement (the
Co-Promotion Agreement ) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany. In addition, AMP will organize with the support of CC Pharma, information events in Germany to market Aphria branded products to doctors and pharmacists. ....

United States , Rheinland Pfalz , Holger Scholze , Pharma Gmb , Alex Blodgett , Stefan Feuerstein , Tamara Macgregor , Wieland Schinnenburg , Hendrik Knopp , German Cannabis Group Inc , German Cannabis Group , Toronto Stock Exchange , Aphria Inc , European Union , Regulation Services Provider , Corporate Affairs , Cannabis Group , Co Promotion Agreement , Managing Director , Aphria Germany Gmbh , Latin America , Cannabis Act , Manufacturing Practice , Roundtable Series , Medical Cannabis , Chief Corporate Affairs Officer ,